02.04.2015 • News

Sale of DSM Synres Completed

Dutch life sciences and materials sciences company DSM has finalised the sale of DSM Synres to private equity firm Standard Investment. Financial details of the sale, which was announced on December 17 last year, were not disclosed.

DSM Synres produces solvent-borne alkyd and acrylic coating resins at its site in Hoek van Holland for the global coatings, adhesives and graphic arts markets. It has sales of around €50 million and about 80 employees.

Standard Investment, based in Amsterdam, focuses on small and medium-sized enterprises in the Netherlands and Belgium. It has acquired 18 companies since its establishment in 2004.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.